As of 2023, over 3.5 million cases have been reported in the Americas.2
Acute chikungunya affects up to 97% of those infected.3
Up to 43% of patients progress to chronic disease, characterized by joint pain and/or fatigue, with potential debilitating impact, that can last from months to years.1
The majority of those with severe chikungunya infection do not return to their previous health status.4
Chikungunya is currently a major global public health threat.5
As of 2023, over 3.5 million cases have been reported in the Americas.2